Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats

doi:10.3748/wjg.v18.i17.2084

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4691)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

493

HTML

3614

Figures (1-6)

352

Tables (1-1)

232

Sum=4691

May 7, 2012 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 7, 2012; 18(17): 2084-2091
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2084

Full Size Figure Download Figure

Figure 6 Photomicrographs of liver sections. All cirrhotic rats developed micronodular cirrhosis with regeneration nodules, necrosis and steatosis regardless of treatment (A: Cirrhosis; B: Cirrhosis + IGF-1; C: Cirrhosis + rifaximin). All control rats showed normal cellular architecture (D: Control; E: Control + IGF-1; F: Control + rifaximin).

Citation: Òdena G, Miquel M, Serafín A, Galan A, Morillas R, Planas R, Bartolí R. Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats. World J Gastroenterol 2012; 18(17): 2084-2091
URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2084.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2084